{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:07:46Z","timestamp":1784070466347,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xkme.2026.101253","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:30:29Z","timestamp":1767889829000},"page":"101253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Daratumumab for Treatment of Refractory Podocytopathy: A Case Report"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-6086","authenticated-orcid":false,"given":"Andreia","family":"Curto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Martinez Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah S.","family":"Geara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xkme.2026.101253_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/gfae166","article-title":"Antibody-mediated podocytopathies: a disease entity that implies immunotherapy","volume":"40","author":"Kronbichler","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2026.101253_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101253_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa2314471","article-title":"Autoantibodies targeting Nephrin in podocytopathies","volume":"391","author":"Hengel","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101253_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting Nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101253_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.kint.2024.07.022","article-title":"Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft","volume":"106","author":"Batal","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2026.101253_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.kint.2024.09.006","article-title":"Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants","volume":"106","author":"Raglianti","year":"2024","journal-title":"Kidney Int"},{"issue":"4S","key":"10.1016\/j.xkme.2026.101253_bib7","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2026.101253_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ndt\/gfac228","article-title":"Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects","volume":"38","author":"Sinha","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2026.101253_bib9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2215\/CJN.05080610","article-title":"Rituximab therapy in idiopathic membranous nephropathy: a 2-year study","volume":"5","author":"Fervenza","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101253_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232896","article-title":"Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness","volume":"13","author":"Podest\u00e0","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"589","key":"10.1016\/j.xkme.2026.101253_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc3961","article-title":"Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia","volume":"13","author":"Crickx","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xkme.2026.101253_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108635","article-title":"Novel treatment options in rituximab-resistant membranous nephropathy patients","volume":"107","author":"Ahmadian","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101253_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nefro.2023.03.003","article-title":"Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment","volume":"44","author":"de la Prada \u00c1lvarez","year":"2024","journal-title":"Nefrologia"},{"issue":"6","key":"10.1016\/j.xkme.2026.101253_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2020.02.444","article-title":"Successful treatment of patients with refractory PLA2R-associated membranous nephropathy with obinutuzumab: a report of 3 cases","volume":"76","author":"Klomjit","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101253_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003604","article-title":"Daratumumab for autoimmune diseases: a systematic review","volume":"9","author":"Holzer","year":"2023","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.xkme.2026.101253_bib16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.ajt.2024.06.010","article-title":"Rescue with obinutuzumab and daratumumab as combined B cell\/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence","volume":"24","author":"Randone","year":"2024","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2026.101253_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1681\/ASN.0000000520","article-title":"Long-term outcomes of rituximab-treated adult patients with podocytopathies","volume":"36","author":"Gauckler","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101253_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10157-017-1415-8","article-title":"Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion","volume":"22","author":"Sato","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101253_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-024-06570-8","article-title":"Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion","volume":"40","author":"Chan","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101253_bib20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.0000000000000288","article-title":"Obinutuzumab in frequently relapsing and steroid-dependent nephrotic syndrome in children","volume":"18","author":"Dossier","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101253_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100853","article-title":"Obinutuzumab in refractory membranous nephropathy: a case series","volume":"6","author":"Lin","year":"2024","journal-title":"Kidney Med"},{"issue":"9","key":"10.1016\/j.xkme.2026.101253_bib22","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302214","article-title":"B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses","volume":"6","author":"Verhoeven","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.xkme.2026.101253_bib23","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3389\/fimmu.2019.02221","article-title":"CD27+CD38hi B cell frequency during remission predicts relapsing disease in granulomatosis with polyangiitis patients","volume":"10","author":"von Borstel","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101253_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00467-020-04811-0","article-title":"A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome","volume":"36","author":"Dossier","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101253_bib25","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ekir.2024.04.006","article-title":"Combined rituximab and daratumumab treatment in difficult-to-treat nephrotic syndrome cases","volume":"9","author":"Angeletti","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.xkme.2026.101253_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ajt.2023.12.010","article-title":"Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis","volume":"24","author":"Angeletti","year":"2024","journal-title":"Am J Transplant"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:22:47Z","timestamp":1784067767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2590059526000142"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101253","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daratumumab for Treatment of Refractory Podocytopathy: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101253"}}